Auna S.A.

AUNA

Medical - Care Facilities · Healthcare

Price

$5.32

+0.12 (+2.31%)

Market Cap

$393.8M

Exchange

New York Stock Exchange

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 9, 2026 · filings through Mar 31, 2026

Share count falling — buybacks

−37.2% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 47.9M (2021) → 30.1M (2025)

Auna S.A. is a healthcare company that runs hospitals, clinics, and cancer treatment centers in Latin America. It serves regular patients who need medical care, from routine checkups to complex cancer treatments. Auna operates primarily in Peru, Mexico, and Colombia, making it one of the larger private healthcare networks in the region.

Auna makes money by charging patients and insurance companies for medical services, including hospital stays, outpatient visits, and specialized oncology care. The company has built a network of facilities across three countries, giving it scale that smaller local providers cannot easily match. With a market cap around $0.4 billion, it is a mid-sized player in a fragmented market where growing middle-class populations and rising demand for private healthcare are the main growth drivers — though the company also carries meaningful debt from expanding its network, which remains a key financial risk.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+13.0% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-81.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

24.1%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$461M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Auna S.A. is a rare growth stock that's already generating positive cash flow while growing at 13%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

36.6%

Modest — 36.6% gross margin

Operating Margin

13.1%

Healthy — 13.1% operating margin

ROCE

2.9%

Weak — 2.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+3.9%

Slow sales growth (+3.9% YoY)

EPS YoY

-112.5%

Earnings shrinking (-112.5% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

882%

Turns 882% of profit into real cash

FCF Margin

10.9%

Modest free cash flow (10.9%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

2.12

Heavy debt load (2.12)

Interest Cover

1.55x

Dangerous — barely covers interest (1.6x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial